Pyrimidine compounds as mTOR and PI3K inhibitors

The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.

Saved in:
Bibliographic Details
Main Authors Tsai Ping-Kuei, Kuo Mann-Yan, Huang Yi-Ting, Chen Li Jung, Lee Ying-Shuan, Lu Yann Yu, Chen Paonien, Hsu Hung-Yi
Format Patent
LanguageEnglish
Published 31.10.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pyrimidine compounds of formula (I): which are useful in treating mTOR kinase- or PI3K kinase-related diseases.
Bibliography:Application Number: US201615002806